Financials

  • Market Capitalization 343.1 M
  • Employee 120
  • Founded 1995
  • CEO N/A
  • Website www.enanta.com
  • Headquarter Massachusetts, United States
  • FIGI BBG001V9NSB4
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.12
Relación precio/flujo de caja
0

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3097
CCCC
C4 Therapeutics, Inc. - Common Stock
2.87 USD-6.21%-1.37%-17.05%+36.67%353.08 M USD
3118
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
5.74 USD-2.88%-2.21%-6.06%+79.38%345.00 M USD
3129
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
12.01 USD-4.76%-9.29%-17.85%-36.72%341.36 M USD
3131
TTRX
Turn Therapeutics Inc. - Common Stock
10.86 USD-2.25%-8.89%-12.63%+75.16%323.50 M USD

Noticias